2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Primary Dysautonomias: new trials by email Literature Review of Primary Dysautonomias trials Research Report on Primary Dysautonomias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Contributions to Hypertension With Androgen Deprivation Therapy Gonadotropin Releasing Hormone Agonists (GNRH), Androgen receptor (AR) inhibitor, Placebo - Androgen Deprivation Therapy, Prostate Cancer | Phase 4 | Terminated | University of Colorado, Denver | 10 | 2023-09-20 | 2026-09-02 |
| A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension midodrine hydrochloride (ProAmatine®) - Hypotension, Orthostatic | Phase 4 | Terminated | Shire | 150 | 2002-09-05 | 2021-06-29 |
Hypertension (1) · Hypotension, Orthostatic (1) · Kidney Diseases (1) · Prostatic Neoplasms (1)
Autonomic Nervous System Diseases (2) · Cardiovascular Diseases (2) · Nervous System Diseases (2) · Vascular Diseases (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Hypotension (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Orthostatic Intolerance (1)
Flutamide (1) · Goserelin (1) · Leuprolide (1) · Midodrine (1) · Receptors, Androgen (1) · bicalutamide (1) · enzalutamide (1)
Shire (1) · University of Colorado, Denver (1)
United States (2)